Using the GuruFocus Aggregated Portfolio Screener you can filter results to see what companies were bought by the largest numbers of gurus over a certain period of time. By using this screener, we filtered down to see which companies based in Europe were bought by the highest number of gurus.
The following five companies come from a variety of industries, are European-based and were bought by the largest number of gurus over the past quarter.
Royal Dutch Shell PLC (RDS.A)
Over the past quarter there were 7 gurus making buys into Royal Dutch Shell, bringing the total number of guru owners to 20. There were also eleven gurus selling part or the entirety of their stake in the company. These guru owners maintain a combined weighting of 8.23%.
The top guru shareholders of RDS.A:
1. Dodge & Cox: 10,939,428 shares, representing 0.35% of the company’s shares outstanding.
2. Richard Pzena: 6,965,119 shares, representing 0.22% of the company’s shares outstanding.
3. Brian Rogers (Trades, Portfolio): 5,819,200 shares, representing 0.18% of the company’s shares outstanding.
Royal Dutch Shell is a UK-incorporated company headquartered out of The Hague, Netherlands. The company is an integrated oil and gas company. Its operating segments consist of Upstream, Downstream and Projects & Technology.
Royal Dutch Shell’s historical revenue and net income:
The analysis on Royal Dutch Shell reports that the company’s asset growth is currently faster than its revenue growth, its revenue has been in decline over the past year and its price is sitting near a 5-year high.
The Peter Lynch Chart suggests that the company is currently undervalued:
Royal Dutch Shell has a market cap of $229.01 billion. Its shares are currently trading at around $72.30 with a P/E ratio of 11.40, a P/S ratio of 0.50 and a P/B ratio of 1.38. The dividend yield of Royal Dutch Shell stocks is at 5.00%. The company had an annual average earnings growth of 0.30% over the past five years.
TE Connectivity Ltd. (TEL)
The second most-held European stock was TE Connectivity. There were 7 gurus making buys of Novartis stock over the past quarter and eleven gurus making sells of their stake in the company. Novartis currently boasts 19 guru owners of the company that maintain a combined weighting of 17.51%.
The top guru shareholders of TE Connectivity:
1. Dodge & Cox: 35,191,231 shares, representing 8.51% of the company’s shares outstanding.
2. Bill Nygren (Trades, Portfolio): 4,686,000 shares, representing 1.13% of the company’s shares outstanding.
3. Charles Brandes (Trades, Portfolio): 4,487,405 shares, representing 1.09% of the company’s shares outstanding.
TE Connectivity Ltd is a company that designs and manufactures electronic products that connect and protect the flow of power and data.
TE Connectivity’s historical revenue and net income:
]
The analysis on TE Connectivity reports that the company’s revenue has slowed down over the past year, its price is near a 10-year high and its P/B and P/S ratios are near 10-year highs.
The Peter Lynch Chart suggests that the company is currently overvalued:
TE Connectivity has a market cap of $23.65 billion. Its shares are currently trading at around $57.66 with a P/E ratio of 18.00, a P/S ratio of 1.80 and a P/B ratio of 2.70. The dividend yield of TE Connectivity is currently at 1.70%.
Novartis AG (NVS)
The third most-held European stock was Novartis. There were 6 gurus making buys of Novartis stock over the past quarter and 8 gurus making sells of their stake in the company. Novartis currently boasts 19 guru owners of the company that maintain a combined weighting of 13.31%.
The top guru shareholders of Novartis:
1. Dodge & Cox: 46,485,352 shares, representing 1.9% of the company’s shares outstanding.
2. PRIMECAP: 26,720,705 shares, representing 1.09% of the company’s shares outstanding.
3. Ken Fisher: 5,787,120 shares, representing 0.24% of the company’s shares outstanding.
Novartis provides healthcare solutions that address the evolving needs of patients and societies worldwide with a portfolio that includes innovative medicines, preventive vaccines and diagnostic tools, generic pharmaceuticals and consumer health products. The company’s businesses are divided worldwide into these four operating divisions: Pharmaceuticals, Vaccines and Diagnostics, Sandoz and Consumer Health.
Novartis’ historical revenue and net income:
The analysis on Novartis reports that the company’s revenue has slowed down over the past year, its dividend yield is near a 5-year low, its price is near a 10-year high and its operating margin is expanding.
The Peter Lynch Chart suggests that the company is currently overvalued:
Novartis has a market cap of $200.39 billion. Its shares are currently trading at around $82.60 with a P/E ratio of 22.20, a P/S ratio of 3.50 and a P/B ratio of 2.71. The dividend yield of Novartis stocks is 3.30%. The company had an annual average earnings growth of 7.3% over the past ten years.
GuruFocus rated Novartis the business predictability rank of 4-star.
Transocean (RIG)
The fourth most-held stock was in Transocean. There were also nine gurus making buys of this company’s stock. Along with these buys there were nine gurus making sells. As of the fourth quarter there were 17 guru owners of Transocean stock. These gurus hold a combined weighting of 11.59%.
The top guru shareholder of Transocean stock:
1. Carl Icahn (Trades, Portfolio): 21,477,900 shares, representing 5.96% of the company’s shares outstanding.
2. PRIMECAP: 11,466,474 shares, representing 3.18% of the company’s shares outstanding.
3. Leon Cooperman (Trades, Portfolio): 3,483,545 shares, representing 0.97% of the company’s shares outstanding.
Transocean is a Swiss company that is an international provider of offshore contract drilling services for oil and gas wells. The company's business is to contract its drilling rigs, related equipment and work crews on a day-rate basis to drill oil and gas wells.
Transocean’s historical revenue and net income:
The analysis on Transocean reports that the company’s revenue has been in decline over the past five years, its Piotroski F-Score indicates a healthy situation and its dividend yield is at a 1-year high.
The Peter Lynch Chart suggests that the company is currently undervalued:
Transocean has a market cap of $14.94 billion. Its shares are currently trading at around $41.39 with a P/E ratio of 10.70, a P/S ratio of 1.60 and a P/B ratio of 0.90. The company’s dividend yield is currently at 5.40%.
Sanofi (SNY)
Over the past quarter there were eight gurus making buys of Sanofi stock. Along with these gurus there were also five gurus selling some or all of their shares of the company’s stock. As of the third quarter there were 16 guru owners holding a combined weighting of 12.80%.
The top guru shareholders of Sanofi:
1. Dodge & Cox: 43,628,729 shares, representing 1.64% of the company’s shares outstanding.
2. James Barrow (Trades, Portfolio): 22,645,140 shares, representing 0.85% of the company’s shares outstanding.
3. Ken Fisher (Trades, Portfolio): 12,818,390 shares, representing 0.48% of the company’s shares outstanding.
Sanofi is a Paris-based healthcare company focused on patient needs and engaged in the research, development, manufacture and marketing of healthcare products. The company also discovers, develops and distributes therapeutic solutions.
Sanofi’s historical revenue and net income:
The analysis on Sanofi reports that the company’s revenue has been in decline over the past five years, its dividend yield is also at a 5-year low and its price is sitting near a 10-year high.
The Peter Lynch Chart suggests that the company is currently overvalued:
Sanofi has a market cap of $134.31 billion. Its shares are currently trading at around $50.71 with a P/E ratio of 26.60and a P/S ratio of 2.90. The dividend yield of Sanofi stocks is 2.60%. Sanofi had an annual average earnings growth of 14.80% over the past ten years.
You can check out other top held sectors of the market by using the Aggregated Screener here.
Try a free 7-day premium membership.
